Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of RTS,S/AS01 in Healthy Thai Adults
NCT02992119Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Jun 2017
- Primary completion
- Feb 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of RTS,S in malaria (7 arms), sponsored by University of Oxford. Primary endpoints: Serious Adverse Events, Seroconversion Rate and 1 more. Started Jun 2017; status: completed.
02
Drugs
RTS,S
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02992119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02992119.